CME Group
CME
CME Group (CME) earnings history
Most recent quarter
- Fiscal period
- Q2 2026
- Period end
- Jun 30, 2026
- EPS actual
- $2.99
- EPS estimate
- $2.91
- EPS surprise
- +2.92%
- Revenue surprise
- +1.43%
- Revenue
- $1.7B
- Revenue estimate
- $1.7B
- Reported
- Jul 22, 2026
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Jul 22, 2026 | $2.91 | $2.99 | +2.92% | $1.7B | SEC |
| Q1 2026 | Apr 22, 2026 | $3.34 | $3.36 | +0.51% | $1.9B | SEC |
| Q4 2025 | Feb 4, 2026 | $2.75 | $2.77 | +0.75% | $1.6B | SEC |
| Q3 2025 | Oct 22, 2025 | $2.63 | $2.68 | +1.93% | $1.5B | SEC |
| Q2 2025 | Jul 23, 2025 | $2.91 | $2.96 | +1.58% | $1.7B | SEC |
| Q1 2025 | Apr 23, 2025 | $2.80 | $2.80 | −0.13% | $1.6B | SEC |
| Q4 2024 | Feb 12, 2025 | $2.45 | $2.52 | +3.03% | $1.5B | SEC |
| Q3 2024 | Oct 23, 2024 | $2.65 | $2.68 | +1.04% | $1.6B | SEC |
| Q2 2024 | Jul 24, 2024 | $2.53 | $2.56 | +1.06% | $1.5B | SEC |
| Q1 2024 | Apr 24, 2024 | $2.45 | $2.50 | +1.99% | $1.5B | SEC |
| Q4 2023 | Feb 14, 2024 | $2.28 | $2.37 | +3.83% | $1.4B | SEC |
| Q3 2023 | Oct 25, 2023 | $2.22 | $2.25 | +1.23% | $1.3B | SEC |
| Q2 2023 | Jul 26, 2023 | $2.20 | $2.30 | +4.50% | $1.4B | SEC |
| Q1 2023 | Apr 26, 2023 | $2.37 | $2.42 | +1.90% | $1.4B | SEC |
| Q4 2022 | Feb 8, 2023 | $1.88 | $1.92 | +2.04% | $1.2B | SEC |
| Q3 2022 | Oct 26, 2022 | $1.94 | $1.98 | +2.10% | $1.2B | SEC |
| Q2 2022 | Jul 27, 2022 | $1.93 | $1.97 | +1.84% | $1.2B | SEC |
| Q1 2022 | Apr 27, 2022 | $2.00 | $2.11 | +5.29% | $1.3B | SEC |
| Q4 2021 | Feb 9, 2022 | $1.64 | $1.66 | +1.22% | $1.1B | SEC |
| Q3 2021 | Oct 27, 2021 | $1.55 | $1.60 | +3.13% | $1.1B | SEC |
Quarterly revenue
Frequently asked questions
When did CME Group (CME) last report earnings?
CME Group last reported on Jul 22, 2026, covering fiscal Q2 2026.
Did CME beat earnings estimates?
Yes. CME Group reported EPS of $2.99 for Q2 2026 against a $2.91 estimate — a 2.92% beat.
How much revenue did CME report last quarter?
CME Group reported $1.7B in revenue for Q2 2026, against a consensus estimate of $1.7B.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.